BlinkBio, Inc.
PrivateLast Round
Convertible Debt
Aug 19, 2020
Total Funding Raised
$26.7M
Company Overview
BlinkBio, Inc. is a biotechnology company that develops Tunable Drug Conjugates (TDCs) for the treatment of oncology and other diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BlinkBio, Inc. Comparables
Compare BlinkBio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shasqi | 82% | |
| Cybrexa Therapeutics | 81% | |
| OS Therapies | 80% |
BlinkBio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Aug 19, 2020 | ||||
| Grant | Mar 1, 2017 | ||||
| Series A | Oct 27, 2016 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 30, 2025
Monthly visitors increased 127% MoM.
- Mar 1, 2017
Secured $300K in grant funding.
BlinkBio, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BlinkBio, Inc.'s valuation, stock price, and market status.
Is BlinkBio, Inc. a public or private company?
BlinkBio, Inc. is a private company.
What is the current stock price of BlinkBio, Inc.?
BlinkBio, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is BlinkBio, Inc. worth (valuation)?
Valuation information for BlinkBio, Inc. is not publicly available.
Can I buy BlinkBio, Inc. stock?
BlinkBio, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was BlinkBio, Inc.'s last funding round?
BlinkBio, Inc.'s most recent funding round was Convertible Debt on August 19, 2020.
Who are the main investors in BlinkBio, Inc.?
Investor information for BlinkBio, Inc. is not publicly disclosed.
Will BlinkBio, Inc. IPO soon?
No public IPO plans have been announced for BlinkBio, Inc..
How can I track BlinkBio, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BlinkBio, Inc.'s secondary market activity and sign up for updates.